A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China.
Fengkui ZhangAizong ShenWaqas AhmedRichard F PollockPublished in: Advances in therapy (2024)
The results showed that FDI would improve patient quality of life and reduce direct healthcare expenditure versus FCM in patients with IDA in China.